Physical Medicine & Rehabilitation · Roseville, MI
NPI
1548230253
Since 2006
Specialty
Physical Medicine & Rehabilitation
Code 208100000X
Group practices
3
Medicare group memberships
Hospitals
4
Hospital affiliations
25100 Kelly Rd
Roseville, MI, 48066
Phone (248) 553-0010
Groups this clinician bills Medicare through
Medicare paid, 2024
$280K
45,186 services
Medicare patients, 2024
137
Average age 45
Drug cost, 2024
$993K
1,719 prescriptions
Company payments, 2025
$21K
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Edward R Dabrowski was code J0585 (injection, onabotulinumtoxina, 1 unit), 26,360 times for 26 patients. In total Edward R Dabrowski billed 45,186 services in 18 codes, and Medicare paid $280K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-03-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 26,360 | 26 | $4.73 | $125K |
| J0586 Injection, abobotulinumtoxina, 5 units | Office | 13,960 | 28 | $6.48 | $90K |
| 99213 Office E&M - Established | Office | 175 | 95 | $56.81 | $9,941 |
| 64642 Musculoskeletal | Office | 119 | 51 | $115.95 | $14K |
| 64643 Musculoskeletal | Office | 112 | 43 | $72.79 | $8,152 |
| 99214 Office E&M - Established | Office | 55 | 43 | $93.59 | $5,147 |
By year: 2022 $262K for 41,476 services; 2023 $288K for 47,038 services; 2024 $280K for 45,186 services.
Medicare prescription drug claims, 2024
In 2024, the drug Edward R Dabrowski prescribed most often to Medicare patients was Clonazepam, with 245 prescriptions and refills. In total Edward R Dabrowski wrote 1,719 Medicare prescriptions that cost $993K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Clonazepam Generic | 245 | 307 | 35 | $8,340 |
| Baclofen Generic | 180 | 269 | 34 | $32K |
| Gabapentin Generic | 82 | 101 | 15 | $1,692 |
| Dantrolene Sodium Generic | 76 | 90 | 12 | $7,077 |
| Levetiracetam Generic | 62 | 86 | Under 11 | $3,105 |
| Fluoxetine Hcl Generic | 47 | 75 | Under 11 | $647 |
| Duloxetine Hcl Generic | 45 | 93 | Under 11 | $1,613 |
| Cyclobenzaprine Hcl Generic | 43 | 59 | Under 11 | $445 |
| Diazepam Generic | 40 | 76 | 11 | $229 |
| Risperidone Generic | 35 | 66 | Under 11 | $1,783 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 31 | 41 | Under 11 | $516 |
| Pregabalin Generic | 30 | 32 | Under 11 | $290 |
| Carbamazepine Er Carbamazepine | 27 | 49 | Under 11 | $3,353 |
| Amantadine Amantadine Hcl | 25 | 41 | Under 11 | $1,824 |
| Chlorpromazine Hcl Generic | 24 | 24 | Under 11 | $14K |
Brand drugs: - claims; generic drugs: 1,587 claims; opioid claims: 23.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Edward R Dabrowski $21K ($21K in general payments such as food, travel and fees) from 15 companies. The largest payer was Ipsen Biopharmaceuticals, Inc with $8,235.
| Company | Payments | Amount |
|---|---|---|
| Ipsen Biopharmaceuticals, Inc IPN.PA | 25 | $8,235 |
| Abbvie Inc. ABBV | 9 | $6,574 |
| ACADIA Pharmaceuticals Inc ACAD | 9 | $5,778 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 2 | $236 |
| Biogen, Inc. BIIB | 6 | $162 |
| Neurelis, Inc. | 5 | $115 |
| Merz Pharmaceuticals, LLC | 2 | $43.94 |
| Janssen Biotech, Inc. JNJ | 1 | $36.04 |
| Supernus Pharmaceuticals, Inc. SUPN | 2 | $33.8 |
| Ultragenyx Pharmaceutical Inc. RARE | 1 | $25.83 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.